ArticlePublic health action2026
Parenteral artesunate compliance and hospital outcomes in children under five with suspected severe malaria in Sierra Leone.
Article in Public health action, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo assess compliance with national malaria guidelines for confirmatory diagnosis and parenteral artesunate administration, and to evaluate hospital exit outcomes among children under five admitted with suspected severe malaria.
designA cohort study utilising routinely collected data in Ola During Children's Hospital, a tertiary paediatric hospital in Freetown, Sierra Leone, from January to December 2024.
resultsOf 735 admitted children (55% male), 657 (89%) underwent rapid diagnostic tests, but none had microscopic confirmation. A total of 650 (88%) received all three recommended doses of parenteral artesunate at 0, 12, and 24 h. Among the remaining 85 children, 48 (56%) received one or two doses, and 37 received none. Two children died before completion of 24-h dosing schedule. Correct weight-based dosing and scheduling were administered in 420 children (parenteral artesunate compliance = 57% [420/733]). Among admissions, 642 (87%) were discharged and 73 (10%) had unfavourable hospital exit outcomes, including 59 deaths, 13 discharged against medical advice, and 1 absconded. Underweight status, multiple convulsions, and failure to receive correct artesunate dosing were associated with unfavourable hospital exit outcomes.
conclusionCompliance with recommended parenteral artesunate dosing was suboptimal, potentially contributing to unfavourable hospital outcomes. Strengthened monitoring, mentorship, and enforcement of malaria management guidelines are urgently needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.